This is not the most recent version of the article. View current version (2 APR 2014)
Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis
Editorial Group: Cochrane Cystic Fibrosis and Genetic Disorders Group
Published Online: 6 JUL 2011
Assessed as up-to-date: 13 JUN 2011
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Amin R, Waters V. Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis (Protocol). Cochrane Database of Systematic Reviews 2011, Issue 7. Art. No.: CD009249. DOI: 10.1002/14651858.CD009249.
- Publication Status: New
- Published Online: 6 JUL 2011
This is not the most recent version of the article. View current version (02 APR 2014)
This is the protocol for a review and there is no abstract. The objectives are as follows:
The objective of our review is to assess the effectiveness of antibiotic treatment for S. maltophilia in people with CF. The primary objective is to assess this in relation to lung function and pulmonary exacerbations in the setting of acute pulmonary exacerbations and suppressive antibiotic therapy. The secondary objective is to assess this in relation to the eradication of S. maltophilia.